Table 3 Factors associated with UAC at the start of treatment in cytotoxic drug users (Multivariate Analysis).
Factor | Adjusted odds ratio (95% CI) | p-value |
|---|---|---|
TP | 0.72 (0.43–1.22) | 0.22 |
ALB | 0.90 (0.42–1.91) | 0.78 |
UN | 1.05 (1.00–1.10) | 0.04* |
CRE | 0.43 (0.08–2.25) | 0.31 |
eGFR | 0.99 (0.97–1.00) | 0.14 |
Na | 0.83 (0.73–0.95) | 0.01* |
Cl | 1.10 (0.98–1.23) | 0.12 |
Ca | 0.71 (0.33–1.51) | 0.38 |
γ-GTP | 1.00 (0.99–1.00) | 0.85 |
ALP | 1.00 (1.00–1.00) | 0.49 |
LDH | 1.00 (0.99–1.00) | 0.76 |
CRP | 1.05 (0.94–1.18) | 0.40 |
RBC | 1.01 (0.99–1.01) | 0.15 |
Hb | 0.87 (0.67–1.13) | 0.30 |
Plt | 0.97 (0.94–1.00) | 0.08 |
Lymp | 0.99 (0.94–1.04) | 0.70 |
Mono | 0.92 (0.81–1.04) | 0.19 |